Type
. A study of low clinic attendance of leprosy patients: reasons and solutions. Indian journal of leprosy. 1998;70 Suppl:17S-21S.
Type
. Incidence of disabilities among multi-bacillary cases after initiation of multidrug therapy and factors associated with the risk of developing disabilities. Indian journal of leprosy. 1998;70 Suppl:11S-16S.
Type
. Can general practitioners carry out drug delivery and periodic examination of leprosy patients in Raipur city?. Indian journal of leprosy. 1998;70 Suppl:5S-9S.
Type
. Health systems research: a management tool for solving problems. Indian journal of leprosy. 1998;70 Suppl:1S-3S.
Type
. [Leprosy and its cutaneous and neurologic manifestations]. Revue medicale de Liege. 2000;55(6):577-80.
Type
. Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice. Antimicrobial agents and chemotherapy [Internet]. 2000;44(10):2919-21. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC90182/pdf/ac002919.pdf
Type
. [Health in Guinea: a model system of primary health care revisited]. Medecine tropicale : revue du Corps de sante colonial. 2000;60(1):25-8.
Type
. Detection of leprosy in ancient human skeletal remains by molecular identification of Mycobacterium leprae. American journal of clinical pathology. 2000;114(3):428-36.
Type
. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline. Acta leprologica. 1999;11(4):179-82.
Type
. [Randomized controlled trial of medical and medico-surgical treatment of Hansen's neuritis]. Acta leprologica. 1999;11(4):171-7.